Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Domenyuk, Valeriy ^a   Zhong, Zhenyu ^a   Stark, Adam ^a   Xiao, Nianqing ^a   O'Neill, Heather A ^a   Wei, Xixi ^a   Wang, Jie ^a   Tinder, Teresa T ^a   Tonapi, Sonal ^a   Duncan, Janet ^a   Hornung, Tassilo ^a   Hunter, Andrew ^a   Miglarese, Mark R ^a   Schorr, Joachim ^a   Halbert, David D ^a   Quackenbush, John ^b,c   Poste, George ^d   Berry, Donald A ^e   Mayer, Günter ^a,f   Famulok, Michael ^a,f,g   Spetzler, David ^a   more..

^a CARIS LIFE SCIENCES   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF BONN   (Germany)

^g CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGODEOXYRIBONUCLEOTIDE; TUMOR MARKER;

AREA UNDER THE CURVE; BLOOD; BREAST TUMOR; DNA SEQUENCE; EXOSOME; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; METABOLISM; PROCEDURES; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE; SYSTEMS BIOLOGY;

AREA UNDER CURVE; BIOMARKERS, TUMOR; BREAST NEOPLASMS; EXOSOMES; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; OLIGODEOXYRIBONUCLEOTIDES; SELEX APTAMER TECHNIQUE; SEQUENCE ANALYSIS, DNA; SYSTEMS BIOLOGY;

EID: 85013377844     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42741     Document Type: Article

References (37)

1. Yu, S. et al. Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol 178, 6867-6875 (2007).
2. Martinez, M. C. & Andriantsitohaina, R. Microparticles in angiogenesis: therapeutic potential. Circ Res 109, 110-119, doi: 10.1161/CIRCRESAHA.110.233049 (2011).
3. Josson, S. et al. Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis. Oncogene 34, 2690-2699, doi: 10.1038/onc.2014.212 (2015).
4. Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature, doi: 10.1038/nature15756 (2015).
5. Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200, 373-383, doi: 10.1083/jcb.201211138 (2013).
6. Baran, J. et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 59, 841-850, doi: 10.1007/s00262-009-0808-2 (2010).
7. Brett, S. I., Kim, Y., Biggs, C. N., Chin, J. L. & Leong, H. S. Extracellular vesicles such as prostate cancer cell fragments as a fluid biopsy for prostate cancer. Prostate Cancer Prostatic Dis 18, 213-220, doi: 10.1038/pcan.2015.17 (2015).
8. Minciacchi, V. R., Freeman, M. R. & Di Vizio, D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol 40, 41-51, doi: 10.1016/j.semcdb.2015.02.010 (2015).
9. Rak, J. & Guha, A. Extracellular vesicles-vehicles that spread cancer genes. Bioessays 34, 489-497, doi: 10.1002/bies.201100169 (2012).
10. Verma, M., Lam, T. K., Hebert, E. & Divi, R. L. Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology. BMC Clin Pathol 15, 6, doi: 10.1186/s12907-015-0005-5 (2015).
11. Brody, E. N. & Gold, L. Aptamers as therapeutic and diagnostic agents. J Biotechnol 74, 5-13 (2000).
12. Famulok, M., Hartig, J. S. & Mayer, G. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Chem. Rev. 107, 3715-3743 (2007).
13. Wilson, D. S. & Szostak, J. W. In vitro selection of functional nucleic acids. Annu Rev Biochem 68, 611-647, doi: 10.1146/annurev.biochem.68.1.611 (1999).
14. Bock, L. C., Griffin, L. C., Latham, J. A., Vermaas, E. H. & Toole, J. J. Selection of Single-Stranded-DNA Molecules That Bind and Inhibit Human Thrombin. Nature 355, 564-566 (1992).
15. Ellington, A. D. & Szostak, J. W. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 355, 850-852, doi: 10.1038/355850a0 (1992).
16. Chu, T., Ebright, J. & Ellington, A. D. Using aptamers to identify and enter cells. Curr Opin Mol Ther 9, 137-144 (2007).
17. Mi, J. et al. In vivo selection of tumor-targeting RNA motifs. Nat Chem Biol 6, 22-24, doi: 10.1038/nchembio.277 (2010).
18. Taylor, D. D. & Shah, S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods, doi: 10.1016/j.ymeth.2015.02.019 (2015).
19. Kalra, H. et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 10, e1001450, doi: 10.1371/journal.pbio.1001450 (2012).
20. Kim, M. S. & Yi, G. S. HMPAS: Human Membrane Protein Analysis System. Proteome Sci 11, S7, doi: 10.1186/1477-5956-11-S1-S7 (2013).
21. Ge, Q. et al. miRNA in plasma exosome is stable under different storage conditions. Molecules 19, 1568-1575, doi: 10.3390/molecules19021568 (2014).
22. Beninson, L. A. et al. Acute stressor exposure modifies plasma exosome-associated heat shock protein 72 (Hsp72) and microRNA (miR-142-5p and miR-203). PLoS One 9, e108748, doi: 10.1371/journal.pone.0108748 (2014).
23. Ostergaard, O. et al. Quantitative proteome profiling of normal human circulating microparticles. J Proteome Res 11, 2154-2163, doi: 10.1021/pr200901p (2012).
24. Pienimaeki-Roemer, A. et al. Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets. Transfusion 55, 507-521, doi: 10.1111/trf.12874 (2015).
25. Krieger, G., Kneba, M., Bolz, I. & Nagel, G. A. Characterization of immune complexes detected by the 125I-C1q binding assay in breast cancer. Clin Immunol Immunopathol 46, 14-23 (1988).
26. Mi, H., Muruganujan, A., Casagrande, J. T. & Thomas, P. D. Large-scale gene function analysis with the PANTHER classification system. Nat Protoc 8, 1551-1566, doi: 10.1038/nprot.2013.092 (2013).
27. Webber, J. et al. Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan) platform. Mol Cell Proteomics 13, 1050-1064, doi: 10.1074/mcp.M113.032136 (2014).
28. Kusnezow, W. et al. Antibody microarray-based profiling of complex specimens: systematic evaluation of labeling strategies. Proteomics 7, 1786-1799, doi: 10.1002/pmic.200600762 (2007).
29. Sanchez-Carbayo, M. Antibody array-based technologies for cancer protein profiling and functional proteomic analyses using serum and tissue specimens. Tumour Biol 31, 103-112, doi: 10.1007/s13277-009-0014-z (2010).
30. Lyu, Y. et al. Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX. Theranostics 6, 1440-1452, doi: 10.7150/thno.15666 (2016).
31. Ye, M. et al. Generating aptamers by cell-SELEX for applications in molecular medicine. Int J Mol Sci 13, 3341-3353, doi: 10.3390/ijms13033341 (2012).
32. Raddatz, M. S. et al. Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. Angew Chem Int Ed Engl 47, 5190-5193, doi: 10.1002/anie.200800216 (2008).
33. Gold, L., Walker, J. J., Wilcox, S. K. & Williams, S. Advances in human proteomics at high scale with the SOMAscan proteomics platform. N Biotechnol 29, 543-549, doi: 10.1016/j.nbt.2011.11.016 (2012).
34. Moon, P. G. et al. Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection. Clin Cancer Res 22, 1757-1766, doi: 10.1158/1078-0432.CCR-15-0654 (2016).
35. Lehar, J., Stockwell, B. R., Giaever, G. & Nislow, C. Combination chemical genetics. Nat Chem Biol 4, 674-681, doi: 10.1038/nchembio.120 (2008).
36. Vinkenborg, J. L., Mayer, G. & Famulok, M. Aptamer-based affinity labeling of proteins. Angew Chem Int Ed Engl 51, 9176-9180, doi: 10.1002/anie.201204174 (2012).
37. Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter 3, Unit 3 22, doi: 10.1002/0471143030.cb0322s30 (2006).